G protein-coupled receptor kinase 4 gene variants in human essential hypertension

Proceedings of the National Academy of Sciences of the United States of America
Robin A FelderPedro A Jose

Abstract

Essential hypertension has a heritability as high as 30-50%, but its genetic cause(s) has not been determined despite intensive investigation. The renal dopaminergic system exerts a pivotal role in maintaining fluid and electrolyte balance and participates in the pathogenesis of genetic hypertension. In genetic hypertension, the ability of dopamine and D(1)-like agonists to increase urinary sodium excretion is impaired. A defective coupling between the D(1) dopamine receptor and the G protein/effector enzyme complex in the proximal tubule of the kidney is the cause of the impaired renal dopaminergic action in genetic rodent and human essential hypertension. We now report that, in human essential hypertension, single nucleotide polymorphisms of a G protein-coupled receptor kinase, GRK4gamma, increase G protein-coupled receptor kinase (GRK) activity and cause the serine phosphorylation and uncoupling of the D(1) receptor from its G protein/effector enzyme complex in the renal proximal tubule and in transfected Chinese hamster ovary cells. Moreover, expressing GRK4gammaA142V but not the wild-type gene in transgenic mice produces hypertension and impairs the diuretic and natriuretic but not the hypotensive effects of D(1)-like agon...Continue Reading

References

Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·C J Chen, M F Lokhandwala
Oct 2, 1992·Cell·X JeunemaitreJ M Lalouel
Jan 1, 1991·Methods in Enzymology·J L Benovic
Oct 1, 1986·Circulation·H le MarecM R Rosen
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·C ChatziantoniouW J Arendshorst
Oct 1, 1994·Journal of the American Society of Nephrology : JASN·A Debska-SlizienA D Baines
Mar 1, 1995·Hypertension·G CasariF Macciardi
Mar 15, 1996·The Journal of Biological Chemistry·R T PremontR J Lefkowitz
May 15, 1996·The Journal of Clinical Investigation·F E AlbrechtP A Jose
Jan 1, 1995·Clinical and Experimental Pharmacology & Physiology. Supplement·Y J GaoA Suzuki
May 1, 1997·The Journal of Clinical Investigation·R GrosR D Feldman
May 23, 1998·Journal of Clinical Pharmacology·J B Post, W H Frishman
Aug 4, 1998·Current Opinion in Neurobiology·C V Carman, J L Benovic
Aug 6, 1998·The Journal of Clinical Investigation·L D AsicoP A Jose
Dec 5, 1998·Pharmacology & Therapeutics·P A JoseR A Felder
Sep 1, 1999·The Journal of Endocrinology·C B BrenninkmeijerS Phaneuf
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M SalleseA De Blasi
Mar 10, 2001·Cell·R P LiftonD S Geller
May 17, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·X X LiP A Jose
Sep 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·C A LadinesP A Jose

❮ Previous
Next ❯

Citations

Jan 31, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Dieter RosskopfRafael Schäfers
Oct 27, 2004·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Renee F RobinsonJohn D Mahan
May 11, 2002·Current Hypertension Reports·Pedro A JoseRobin A Felder
Jan 3, 2006·Current Hypertension Reports·John Edward Jones, Pedro A Jose
Apr 8, 2006·Current Hypertension Reports·Michel BurnierMarc Maillard
Apr 29, 2010·Current Hypertension Reports·Jing Chen
Nov 9, 2010·Current Hypertension Reports·Hironobu SanadaPedro A Jose
Jun 3, 2011·Current Hypertension Reports·Mohammad AsgharTahir Hussain
Mar 13, 2012·Current Hypertension Reports·Raymond C Harris, Ming-Zhi Zhang
Dec 1, 1987·Immunology Letters·H R Gamble, K D Murrell
May 17, 2005·Cellular Signalling·Thierry MétayéJean-Louis Kraimps
Dec 5, 2003·Trends in Pharmacological Sciences·Jonathon M WilletsStefan R Nahorski
May 8, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Cheng-Juan Sun, Wei-Yuan Zhang
Oct 27, 2006·Nature Clinical Practice. Nephrology·Robin A Felder, Pedro A Jose
Aug 8, 2002·Kidney International·Hidetsuna WatanabeRobin A Felder
Jun 13, 2009·The Journal of Biological Chemistry·Van Anthony M VillarPedro A Jose
Nov 14, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Paul N Hopkins, Steven C Hunt
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·Ross D Feldman, Robert Gros
Dec 17, 2008·Current Opinion in Nephrology and Hypertension·John J Gildea
Nov 30, 2011·Current Opinion in Nephrology and Hypertension·Raymond C Harris
Dec 1, 2004·Kidney International·Peiying YuPedro A Jose
Dec 23, 2006·Acta Pharmacologica Sinica·Yi-Lin ZhangXue-Hai Tan
Feb 20, 2007·Annual Review of Physiology·Richard T Premont, Raul R Gainetdinov
Nov 8, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Mordecai P BlausteinW Gil Wier
Sep 4, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Crisanto S EscanoPedro A Jose
Feb 4, 2011·American Journal of Physiology. Renal Physiology·John J GildeaRobin A Felder
Sep 18, 2009·American Journal of Physiology. Renal Physiology·Liza GeorgeMohammad Asghar
Oct 26, 2012·American Journal of Physiology. Renal Physiology·Gaurav ChughMohammad Asghar
May 11, 2004·Human Heredity·Scott M WilliamsJason H Moore
Jul 23, 2011·Circulation Research·Stephen L Belmonte, Burns C Blaxall
Mar 19, 2008·Hypertension·Chunyu ZengPedro A Jose
Oct 30, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Junichi YatabePedro A Jose
May 29, 2012·International Journal of Medical Sciences·Chibo Liu, Bo Xi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.